A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non-muscle-invasive Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • East Valley Urology Center of Arizona, Mesa, Arizona, United States

    Contact: Study coordinator (Alekhya Padavala)
    Contact: Principal Investigator (Harpreet Wadhwa)
  • Arizona Urology Specialists, Tucson, Arizona, United States

  • Arkansas Urology, Little Rock, Arkansas, United States

    Contact: Study coordinator (Katie O'Brien)
    Contact: Principal Investigator (Jonathan Henderson, MD)
  • Unio Specialty Care - A Genesis Healthcare Partners Facility, Bakersfield, California, United States

    Contact: Study coordinator (Evelyn De La Cruz)
    Contact: Principal Investigator (Michael Oefelein, MD)
  • Genesis Research, Downey, California, United States

    Contact: Study coordinator (Michelle Martinez)
    Contact: Principal Investigator (Sepehr Nowfar, MD)
  • Urology Center of Southern California, Murrieta, California, United States

    Contact: Study coordinator (Laura Guerrero)
    Contact: Principal Investigator (Madhumitha Reddy, MD)
  • Advanced Urology Institute, Daytona Beach, Florida, United States

    Contact: Study coordinator (Sara Esposito)
    Contact: Principal Investigator (Samuel Lawindy, MD)
  • University of Florida, Gainesville, Florida, United States

    Contact: Study coordinator (Tian White) · tian.white@ufl.edu
    Contact: Principal Investigator (Padraic O'Malley, MD)
  • Advent Health, Orlando, Florida, United States

    Contact: Study coordinator (Genevieve Rexford) · genevieve.rexford@adventhealth.com
    Contact: Principal Investigator (Zachary Smith, MD)
  • Anna Arundel Urology, Annapolis, Maryland, United States

    Contact: Study coordinator (Megan Lormore)
    Contact: Principal Investigator (Mara Holton, MD)
  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Nnamdi Onochie) · nnamdi_onochie@dfci.harvard.edu
    Contact: Principal Investigator (Matthew Mossanen, MD)
  • Michigan Institute of Urology, Troy, Michigan, United States

    Contact: Study coordinator (Danielle Osterhout)
    Contact: Principal Investigator (Jason Hafron, MD)
  • The Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (Audrey Knight) · Audrey.Knight@osumc.edu
    Contact: Principal Investigator (Debasish Sundi, MD)
  • Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States

    Contact: Study coordinator (Rikki Waldorf) · rwaldorf@curcmb.com
    Contact: Principal Investigator (Abhishek Srivastava, MD)
  • Lowcountry Urology, North Charleston, South Carolina, United States

    Contact: Study coordinator (Madalyn Colbert)
    Contact: Principal Investigator (Justin Ellett, MD)
  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Corey Nixon) · corey.nixon@UTsouthwestern.eduUTsouthwestern.eduTSouthwestern.edu
    Contact: Principal Investigator (Yair Lotan, MD)
  • Urology Partners of North Texas, Fort Worth, Texas, United States

    Contact: Study coordinator (Grace Yoon)
    Contact: Principal Investigator (Adam Hollander, MD)
  • Baylor College of Medicine, Houston, Texas, United States

    Contact: Study coordinator (Rosalind Mouton) · Rosalind.Mouton@bcm.edu
    Contact: Principal Investigator (Seth Paul Lerner, MD)
  • Houston Methodist, Houston, Texas, United States

    Contact: Study coordinator (Karina Lozano) · kplozano@houstonmethodist.org
    Contact: Principal Investigator (Dharam Kaushik, MD)
  • University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Hannah Landry) · landryh@uthscsa.edu
    Contact: Principal Investigator (Ahmed Mansour, MD)
Study leads
  • Seth Lerner, MD

    Principal Investigator

    Baylor College of Medicine